Post Parker Institute for Cancer Immunotherapy and Cancer Research Institute Launch Collaboration on Cancer Neoantigens
Post Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and the Cancer Research Institute Announce Collaboration to Accelerate Immuno-Oncology Research
Post The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy
Post An Initiative Led by Parker Institute for Cancer Immunotherapy and Cancer Research Institute Discovers Keys That Could Unlock Better Personalized Treatments to Destroy Cancer
Post The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Dosed in First-Line Pancreatic Cancer Platform Trial
Post Parker Institute for Cancer Immunotherapy and Cancer Vaccine Coalition Unite to Accelerate Cancer Prevention and Treatment as Momentum Builds for Cancer Vaccines
Post Parker Institute for Cancer Immunotherapy Collaborates with Conquer Cancer and ASCO to Support Promising Cancer Research
Post The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute announced a collaboration focused on neoantigens